Thomas E. Goffman - Concepedia

Author

Thomas E. Goffman

Also Known As

T E Goffman, T Goffman, T. Goffman, T.E. Goffman, THOMAS E. GOFFMAN, Thomas E Goffman, Thomas E. Goffman, Thomas E. Goffman, MD, FACP, Thomas Edward Goffman, Thomas Goffman

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute Eastern Virginia Medical School National Institutes of Health University of Pennsylvania Harold C. Simmons Comprehensive Cancer Center

About

Thomas E. Goffman is an author at National Cancer Institute specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	802
2	Health Sciences	9	9	608
3	Public Health	1	1	35
4	African American Studies	1	1	35
5	Cell Biology	1	1	12

Thomas E. Goffman

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Department Thomas E. Goffman American Journal of Preventive Medicine	2009	209
Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. Peter Mauch, N J Tarbell, H Weinstein, Journal of Clinical Oncology Recurrent HdThyroid AbnormalitiesPathologySurgeryOrthopaedic Surgery	1988	171
Lymphedema of the Arm and Breast in Irradiated Breast Cancer Patients: Risks in an Era of Dramatically Changing Axillary Surgery Thomas E. Goffman, Christine Laronga, Lori Wilson, The Breast Journal Breast EdemaSurgical OncologyBreast OncologyRadiation TherapyMedicine	2004	126
Quality of Life with Well-Differentiated Thyroid Cancer: Treatment Toxicities and Their Reduction April Mendoza, Brian C. Shaffer, Daniel W. Karakla, Thyroid	2004	73
Topical application of nitroxide protects radiation-induced alopecia in guinea pigs Thomas E. Goffman, Daniel O. Cuscela, Joseph Glass, International Journal of Radiation OncologyBiologyPhysics MedicineTopical DrugTopical ApplicationSkin PharmacologyDermatology	1992	71
Stage III Hodgkin's disease: improved survival with combined modality therapy as compared with radiation therapy alone. Peter Mauch, Thomas E. Goffman, David I. Rosenthal, Journal of Clinical Oncology Radiation MedicineStage Iii HodgkinCombined Modality TherapyRadiation TherapyHealth Sciences	1985	69
National cancer institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: Results in anaplastic astrocytoma Francis Sullivan, Laurie L. Herscher, John Cook, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyNational Cancer InstituteHigh-grade GliomaPhase IiRadiation Therapy	1994	65
Long-term follow-up on National Cancer Institute Phase I/II study of glioblastoma multiforme treated with iododeoxyuridine and hyperfractionated irradiation. Thomas E. Goffman, Laura Dachowski, Hunt Bobo, Journal of Clinical Oncology High-grade GliomasGliomaDifferential UptakeNeuro-oncologyRadiation Medicine	1992	57
Primary treatment of large and massive adult sarcomas with iododeoxyuridine and aggressive hyperfractionated irradiation Thomas E. Goffman, Zelig Tochner, E Glatstein Cancer Adaptive RadiotherapySurgical OncologyRadiation MedicinePrimary TreatmentRadiation Therapy	1991	55
Persistent or recurrent acromegaly. Long-term endocrinologic efficacy and neurologic safety of postsurgical radiation therapy Thomas E. Goffman, Rahul Dewan, Richard F. Arakaki, Cancer Pituitary SurgeryPituitary GlandNeurologic SafetyGrowth HormoneHuman Growth	1992	43

Page 1